Cladrim (Cladribine Vials) 1mg/ml x 10 ml

Cladrim (Cladribine) is an injectable chemotherapy solution used for certain blood cancers. This 1mg/ml x 10 ml vial pack is stored at 2-8°C and requires careful handling. Cladrim is prescribed under medical supervision for specific oncology protocols.

Strength

1mg/ml x 10 ml

Pack Size

Storage

2-8°

Manufacturer / TM Owner

FRESENIUS KABI ONCOLOGY LTD

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Cladrim (Cladribine) is prescribed for treating hairy cell leukemia and other blood cancers. It belongs to the purine antimetabolite class and is administered intravenously. Patients often ask 'what is Cladribine used for' when discussing treatment options with healthcare providers.

Side Effects

Cladrim works by interfering with cancer cell growth, helping to reduce tumor size. Common effects include temporary decreases in blood cell counts due to its action on rapidly dividing cells. Patients may experience fatigue or nausea as the body adjusts to treatment.

Precautions & Warnings

Cladrim requires refrigerated storage between 2-8°C and should be protected from light. It must be handled by healthcare professionals using proper safety protocols. Patients should avoid exposure to infections during treatment and report any unusual symptoms immediately.

Avoid Interactions

Cladrim may interact with other medications affecting blood counts or liver function. Alcohol and certain supplements could enhance side effects. Patients should inform their doctor about all current medications before starting Cladrim therapy.

References

Frequently Asked Questions

Cladrim is given as an intravenous infusion by healthcare professionals in a clinical setting.

Common effects include lowered blood cell counts, fatigue, and nausea, which should be monitored by medical staff.

Cladrim requires a prescription and should only be obtained through licensed pharmacies or healthcare providers.

Cladrim vials must be refrigerated between 2-8°C and protected from light until use.

Cladribine's primary uses are for hairy cell leukemia and other specific blood cancers, not multiple myeloma.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.